Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$331K Sell
2,802
-50
-2% -$5.77K 0.17% 111
2026
Q1
$341K Sell
2,852
-50
-2% -$6.56K 0.19% 98
2025
Q4
$395K Hold
2,902
0.24% 90
2025
Q3
$428K Hold
2,902
0.29% 85
2025
Q2
$375K Buy
+2,902
New +$351K 0.3% 85

Other funds holding XYL

Steadtrust's XYL Position: Q2 2026 in Review

Steadtrust reduced its Xylem (XYL) stake by 1.8% in Q2 2026, selling an estimated $5.77K and leaving 2,802 shares worth $331K. The position accounts for 0.17% of the portfolio, ranked #111.

Steadtrust first reported a position in XYL in Q2 2025 and has held it in 5 quarters since. The position peaked at $428K in Q3 2025. 1,087 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Steadtrust held 2,802 shares of Xylem worth $331K as of Q2 2026.
  • Steadtrust sold 50 Xylem shares in Q2 2026, an estimated $5.77K.
  • Xylem made up 0.17% of Steadtrust's portfolio in Q2 2026, its #111 holding.
  • Steadtrust first reported a position in Xylem in Q2 2025 and has held it in 5 quarters since.
  • Steadtrust's Xylem position peaked at $428K in Q3 2025.
  • 1,087 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Steadtrust's 13F filing for Q2 2026, filed 9 Jul 2026.